A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, according to new research.

A type of aggressive, treatment-resistant brain tumor has a distinct population of immune cells that support its growth, ...

Researchers have identified a method to enhance the effectiveness of a promising cancer treatment. They found that modifying ...

A single-center study suggests the surgery is safe and effective even when tumors are large or located in high-risk areas.

The shortage of generic chemotherapy drugs cisplatin and carboplatin that began in early 2023 did not increase short-term ...

Lung cancer remains a leading cause of cancer death globally, with a significant rise in cases among non-smokers attributed ...

More than one-quarter of blood or marrow transplant survivors developed cutaneous malignant neoplasms, according to study results.Researchers identified several risk factors, including older age, ...

After their advanced kidney tumors were surgically removed, nine patients were protected from the cancer returning thanks to ...

Study results show that genetic sensitivity to stress was linked to a 49% higher risk of lung cancer in people of European ...

For technical reasons, the English full text will be published approximately two weeks after the German print edition has been published.

Serplulimab is the world's first anti-PD-1 monoclonal antibody (mAb) approved for first-line treatment of ES-SCLC Serplulimab is the first and only anti-PD-1 mAb approved in the European Union (EU) ...

A recent study published in The Lancet Respiratory Medicine revealed an increase in lung cancer cases among non-smokers, ...